^
+ Follow ATHEROSCLEROTIC PROCESS Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 663193
                    [Title] => FDA review backs ezetimibe and simvastatin combination
                    [Summary] => 

After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone, the Food and Drug Administration has concluded that patients should not stop taking ezetimibe/simvastatin or any cholesterol-lowering medications.

[DatePublished] => 2011-03-06 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) ) )
ATHEROSCLEROTIC PROCESS
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 663193
                    [Title] => FDA review backs ezetimibe and simvastatin combination
                    [Summary] => 

After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone, the Food and Drug Administration has concluded that patients should not stop taking ezetimibe/simvastatin or any cholesterol-lowering medications.

[DatePublished] => 2011-03-06 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with